checkAd

     937  0 Kommentare Magdalena Biosciences Initiates Preclinical Study to Evaluate Plant Extracts to Treat Depression, Anxiety, ADHD and Other Mental Health Indications - Seite 3

    For more information about:

    Jaguar Health, visit https://jaguar.health
    Napo Pharmaceuticals, visit www.napopharma.com
    Napo Therapeutics, visit napotherapeutics.com
    Magdalena Biosciences, visit magdalenabiosciences.com
    Visit Jaguar on LinkedIn: https://www.linkedin.com/company/jaguar-health/
    Visit Jaguar on X: https://twitter.com/Jaguar_Health
    Visit Jaguar on Instagram: https://www.instagram.com/jaguarhealthcommunity/

    Forward-Looking Statements

    Certain statements in this press release constitute "forward-looking statements." These include statements regarding the expectation that this study will help determine what dose as well as the best first therapeutic indication for possible use of the extracts in humans, and the expectation that the extracts may have potential to be approved in the future by the FDA as botanical drugs. In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "expect," "plan," "aim," "anticipate," "could," "intend," "target," "project," "contemplate," "believe," "estimate," "predict," "potential" or "continue" or the negative of these terms or other similar expressions. The forward-looking statements in this release are only predictions. Jaguar has based these forward-looking statements largely on its current expectations and projections about future events. These forward-looking statements speak only as of the date of this release and are subject to a number of risks, uncertainties and assumptions, some of which cannot be predicted or quantified and some of which are beyond Jaguar's control. Except as required by applicable law, Jaguar does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.

    Contact Info:

    hello@jaguar.health
    Jaguar-JAGX

    SOURCE: Jaguar Health, Inc.



    View source version on accesswire.com:
    https://www.accesswire.com/794992/magdalena-biosciences-initiates-prec ...


    The Jaguar Health Stock at the time of publication of the news with a fall of -2,64 % to 0,803USD on Tradegate stock exchange (08. September 2021, 00:26 Uhr).
    Seite 3 von 3



    Accesswire
    0 Follower
    Autor folgen
    Mehr anzeigen
    We’re a newswire service standout and fast becoming an industry disruptor. We provide regional, national and global news to thousands of clients around the world. We’re also leading the way in social engagement, targeting and analytics.
    Mehr anzeigen

    Verfasst von Accesswire
    Magdalena Biosciences Initiates Preclinical Study to Evaluate Plant Extracts to Treat Depression, Anxiety, ADHD and Other Mental Health Indications - Seite 3 Magdalena Biosciences, a joint venture recently formed by Jaguar Health and Filament Health Corp., is focused on developing novel, natural prescription medicines derived from plants for mental health indicationsMagdalena launches corporate …

    Schreibe Deinen Kommentar

    Disclaimer